In the dynamic world of pharmaceuticals, complexities are a given. Among these complexities, the handling of batch failures at CDMOs stands out. This was recently highlighted in an eye-opening interview with Michael Kelly, CEO of NervGen Pharma.
Supporting or terminating relationships?
Kelly’s perspective shines light on the notion that when obstacles surface, having a deep bond with your partners fosters mutual understanding, paving the path towards solutions. Kelly’s experience with growth-related challenges at the CDMO reaffirmed that issues perceived as insurmountable were, in fact, addressable. Instead of impulsively seeking alternative manufacturers, a more synergistic approach was birthed by truly grasping the core challenges.
This approach transcends mere dialogue. It encapsulates mutual respect, profound understanding, and a spirit of collaboration. By empathetic understanding of the CDMO’s challenges, the door was opened for solutions that benefited both entities – including continuous training, adjusting batch expectations, and co-creating beneficial redundancies.
Kelly’s wisdom underlines a universal truth of partnerships across industries: true success isn’t about imposing directives, but rather about cultivating resilient bonds. Such bonds not only weather challenges but transform setbacks into avenues for mutual growth.
In your entrepreneurial journey, let Kelly’s insights serve as a reminder: The depth and quality of your partnerships can be your anchor in the stormiest seas.
Japan, with its intricate business culture that values gestures, words, and commitments, accentuates the importance of trust and mutual respect. Recognizing and navigating these nuances are key to success in such a unique environment.
In your endeavors within the Japanese landscape, place trust in the relationships and build them strong. For steadfast support and insights in Japan, connect with us at stefan.sandstrom@biosector.jp.
Link to the inspirational original interview.
Comments are closed